Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on the Effects of Psilocybin for Patients with Psychogenic Non-Epileptic Seizures (PNES)
FranceStudy of Trastuzumab Deruxtecan for Patients with HER2-Low Breast Cancer and New or Worsening Brain Metastases
AustriaStudy on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients
BulgariaStudy on Betamethasone Sodium Phosphate for Treating Acute Facial Nerve Palsy in Children
SwedenStudy of ION373 Given by Spinal Injection for Patients with Alexander Disease
ItalyStudy of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation
BelgiumStudy on the Effects of Dexamethasone in Patients with Aneurysmal Subarachnoid Hemorrhage
GermanyStudy of ACP-204 for Treating Psychosis in Adults with Alzheimer's Disease
BulgariaStudy on the Safety and Feasibility of Oral Zinc Acetate Dihydrate for Patients with GNAO1-Related Disorders
GermanyStudy of BAN2401 (lecanemab) in people with early stage Alzheimer's disease to evaluate its effectiveness in preventing disease progression
SpainStudy comparing stem cell transplantation versus alemtuzumab, cladribine or ocrelizumab in patients with aggressive relapsing-remitting multiple sclerosis
DenmarkStudy of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy
GermanyThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
